Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC3107 (BCG Vaccine) in Healthy Adults
NCT03363178Phase 1Unknown
- Sponsor
- GC Biopharma
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bcg vaccine in Tuberculosis (TB), sponsored by GC Biopharma. Primary endpoint: Adverse Event at 7 days. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03363178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363178.